IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Drug & Alcohol Screening Services procurement and pricing environment in Europe includes market dynamics, buyer power scores, supply chain vendors with pricing trends and forecasts.
This procurement coverage of the Drug & Alcohol Screening Services market in Europe includes Saliva Test, Hair Follicle Test, Urine Test, Blood Test, Sweat Test, Oral Fluid Test, Nicotine Test, Breath Alcohol Test, DOT Drug Screen and Non-DOT Drug Screen. Standard coding in this coverage includes ISIC-869-Other human health activities, NACE-86.90-Other Human Health Activities, NAICS-621990-All other ambulatory health care services and UNSPSC-85121810-Drug or alcohol screening.
Common market terminology included in the Drug & Alcohol Screening Services procurement coverage includes Drugs of Abuse (Illegal drugs or prescription medicines, such as Oxycodone or Valium, are taken for a nonmedical purpose.), Medical Review Officer (MRO) (A licensed physician in charge of receiving and evaluating laboratory test results submitted by the employer's drug testing program.) and Breath Alcohol Technician (BAT) (A person responsible for instructing and assisting employees during the alcohol testing process.).
The top companies covered in the Drug & Alcohol Screening Services procurement report as suppliers are Psychemedics Corporation, Omega Laboratories Inc., Randox Laboratories Limited, Careerbuilder Inc. and Abbott Laboratories.
The Opportunity Assessment chapter provides a comprehensive market analysis of the Drug & Alcohol Screening Services market in Europe category, including buyer power scoring, market pricing trends, vendor landscape, cost structure, and strategic negotiation levers.
The market pricing trends include the Market Price (2026) per person per test, a five year price forecast and a supply chain risk score. Vendor coverage includes a market share and cost structure breakdown.
Analysis includes a comprehensive SWOT analysis of and recent developments impacting the Drug & Alcohol Screening Services market environment.
The Buyer Power Score chapter assesses key components impacting Drug & Alcohol Screening Services procurement including the recent price trend, forecast price trend, availability of substitutes, switching costs, product specialization, average vendor risk, market share concentration, supply chain risk, price driver volatility and recent price volatility.
These components generate a Buyer Power Score that ranges from -5 (strongly favoring sellers) to +5 (strongly favoring buyers) plus a recommended strategy for procurement specialists.
The Price Environment chapter covers detailed pricing analysis and datasets on Drug & Alcohol Screening Services market environment. This includes insights into market pricing Market Price (2026), price forecasts, volatility, specialization, substitutes and switching costs.
Datasets in the Price Environment chapter include vendor cost structure, breakdowns of wage rates by geography and specialty, key external economic and labor drivers impacting the market and market pricing models.
The Supply Chain & Vendors chapter covers the concentration, risk and diversity of the Drug & Alcohol Screening Services market. This includes datasets on the market’s top suppliers, detailed analysis on the key sourcing risks and supply chain dynamics, with environmental, social and governance (ESG) considerations and scores.
The Business Requirements chapter covers vendor relationships, qualifications, service level agreements and key performance indicators. These inputs provide insight into the planning process through the buying lead time, vendor relationship and vendor qualifications. The sourcing process include key RFP elements like an organizational overview, project budget, selection criteria, project schedule, proposal format, inventory control, cost containment, regulation, quality control, distribution and key contract clauses.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The 2026 benchmark market price for Drug & Alcohol Screening Services is €384 per person per test. Prices have increased at a CAGR of 3.04 from 2023-26.
The top vendors in the Drug & Alcohol Screening Services market include Psychemedics Corporation, Omega Laboratories Inc., Randox Laboratories Limited, Careerbuilder Inc. and Abbott Laboratories.
The top industries supplying the Drug & Alcohol Screening Services market are Other Goods Retailing in Europe, Measuring, Testing & Navigation Equipment Manufacturing in Europe, Waste, Scrap & Other Product Wholesaling n.e.c. in Europe, Basic Chemical Manufacturing in Europe, Computer, Peripheral Equipment & Software Wholesaling in Europe, Computer & Peripheral Equipment Manufacturing in Europe and Glass & Glass Product Manufacturing in Europe.
Extensive supplier competition in Europe strengthens buyer power in drug screening procurement. Low market share concentration within the European drug and alcohol screening services market means buyers encounter a wide field of accredited vendors offering workplace, compliance, and pre-employment screening. With several suppliers, procurement teams can demand tailored service configurations or value-added features, such as rapid turnaround, enhanced reporting, or multilingual support. Strategic sourcing initiatives such as regional benchmarking or aggregating volumes across business units can yield substantial cost savings without compromising service continuity or regulatory compliance.
Regulatory compliance in drug and alcohol screening services can significantly affect pricing through the costs associated with meeting legal requirements and maintaining standards set by governing bodies; for example, services must adhere to guidelines from the European Workplace Drug Testing Society (EWDTS) and comply with ISO/IEC 17025 accreditation standards for laboratories, as well as national health and safety regulations across EU member states. These frameworks often require specific testing protocols, documentation, and certification under European Union Drugs Agency (EUDA) oversight, leading to increased operational costs that are then passed on to clients in the form of higher prices.